|

NZD/USD climbs towards highs of the day on USD fading

  • NZD/USD heads back towards the day's highs on a volatile start to the week.
  • Vaccine hopes keep the bid alive, but positioning is overbought and year-end squaring up could be on the cards.

NZD/USD has rallied since London's mid-morning dealing as the US dollar flips on its head, shedding all of its gains for the day by the final hour of Wall Street. 

At the time of writing, NZD/USD is trading at below water by 0.37% but has climbed some 1.6% from its lows of the day, travelling between 0.7002 and 0.7123. 

NZD/USD burst through low volume nodes in late morning in the New York session from 0.7062 and through the session's point of control at 0.7090 to the current level. 

A number of factors are in play, namely, Brexit, COVID and US stimulus. 

The US dollar had picked up a safe haven bid at the start of the day, hitting a 10-day high, as a fast-spreading new coronavirus strain prevalent in Britain prompted investors to seek safety in the greenback.

Vaccine optimism among the sector's leaders

The US dollar then turned lower on the day in thinner holiday season trading volumes while various reports, citing microbiologists and members of the biotechnology sector, communicated their optimistic views on vaccines.

''It’s a real warning that we need to pay closer attention,” said Jesse Bloom yesterday, an evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle.

“Certainly these mutations are going to spread, and, definitely, the scientific community — we need to monitor these mutations and we need to characterize which ones have effects.”

However, “No one should worry that there is going to be a single catastrophic mutation that suddenly renders all immunity and antibodies useless,” Dr Bloom argued.

“The fact is that you have a thousand big guns pointed at the virus,” said Kartik Chandran, a virologist at the Albert Einstein College of Medicine in New York.

“No matter how the virus twists and weaves, it’s not that easy to find a genetic solution that can really combat all these different antibody specificities, not to mention the other arms of the immune response.”

Biontech CEO: Vaccine works with the new British mutation

Domestically, the bird had been performing well last week following an upbeat global sentiment paired with a rebound in Gross Domestic Produce that beat expectation for the third quarter, Q3.

Q3 growth inched above zero (+0.4%) in the year-on-year gauge with a very solid 14.0% quarter-on-quarter.

Therefore, the Reserve Bank of New Zealand is unlikely to cut rates so soon and for that, the bird was supported. 

In the same vein, the currency was buoyed by comments from the Finance Minister Grant Robertson’s which pointed to a relaxed stance on the bird's recent appreciation.

However, the bird is technically overbought in positioning data as net longs vs USD were at 17% of open interest as of last week, according to CFTC data. This may lead to some positing squaring in the final weeks of the year. 

NZD/USD

Overview
Today last price0.7106
Today Daily Change-0.0029
Today Daily Change %-0.41
Today daily open0.7135
 
Trends
Daily SMA200.7052
Daily SMA500.6861
Daily SMA1000.6746
Daily SMA2000.6493
 
Levels
Previous Daily High0.7156
Previous Daily Low0.711
Previous Weekly High0.7172
Previous Weekly Low0.7054
Previous Monthly High0.7052
Previous Monthly Low0.6589
Daily Fibonacci 38.2%0.7128
Daily Fibonacci 61.8%0.7139
Daily Pivot Point S10.7111
Daily Pivot Point S20.7087
Daily Pivot Point S30.7065
Daily Pivot Point R10.7158
Daily Pivot Point R20.718
Daily Pivot Point R30.7204

Author

Ross J Burland

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

More from Ross J Burland
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD moves sideways below 1.1800 on Christmas Eve

EUR/USD struggles to find direction and trades in a narrow channel below 1.1800 after posting gains for two consecutive days. Bond and stock markets in the US will open at the usual time and close early on Christmas Eve, allowing the trading action to remain subdued. 

GBP/USD keeps range around 1.3500 amid quiet markets

GBP/USD keeps its range trade intact at around 1.3500 on Wednesday. The Pound Sterling holds the upper hand over the US Dollar amid pre-Christmas light trading as traders move to the sidelines heading into the holiday season. 

Gold retreats from record highs, trades below $4,500

Gold retreats after setting a new record-high above $4,520 earlier in the day and trades in a tight range below $4,500 as trading volumes thin out ahead of the Christmas break. The US Dollar selling bias remains unabated on the back of dovish Fed expectations, which continues to act as a tailwind for the bullion amid persistent geopolitical risks.

Bitcoin slips below $87,000 as ETF outflows intensify, whale participation declines

Bitcoin price continues to trade around $86,770 on Wednesday, after failing to break above the $90,000 resistance. US-listed spot ETFs record an outflow of $188.64 million on Tuesday, marking the fourth consecutive day of withdrawals.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Avalanche struggles near $12 as Grayscale files updated form for ETF

Avalanche trades close to $12 by press time on Wednesday, extending the nearly 2% drop from the previous day. Grayscale filed an updated form to convert its Avalanche-focused Trust into an ETF with the US Securities and Exchange Commission.